Proficio Capital Partners LLC Clovis Oncology, Inc. Transaction History

Proficio Capital Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$3.93 - $15.35 $216 - $844	-55 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$12.81 - $25.67 $1,421 - $2,849	-111 Reduced 66.87%	55 $1,000
Q1 2019 May 13, 2019	BUY	$17.66 - $30.28 $2,931 - $5,026	166 New	166 $4,000
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $411 - $692	-14 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $940 - $1,187	14	14 $1,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.